Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart (BORG)

This study has been completed.
Sponsor:
Collaborators:
GlaxoSmithKline
AstraZeneca
Information provided by (Responsible Party):
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT01798992
First received: February 22, 2013
Last updated: May 1, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2009
  Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)